Elsevier

Blood Reviews

Volume 5, Issue 4, December 1991, Pages 245-257
Blood Reviews

Human plasma fractionation and the impact of new technologies on the use and quality of plasma-derived products

https://doi.org/10.1016/0268-960X(91)90016-6Get rights and content

Abstract

Recent years brought several important changes in the domain of human plasma derived products. High purity and effective anti-viral treatment became a reality. This radically improved the quality of patient treatment. At the same time recent discoveries in molecular biology paved the way for the production of several crucial plasma components by recombinant technology.

In the light of these developments the future possibilities for different plasma components production is widely discussed and the eventual benefit of more expensive technologies is being evaluated.

This paper, analyzes and presents methods applied by different producers to obtain plasma derived components preparations. The impact of these technologies, the quality of the products and the future of the plasma industry is being discussed.

Reference (64)

  • CohenH et al.

    Plasma, plasma products, and indications for their use

    Plasmapheresis

    (1990)
  • KistlerP et al.

    Ethanol precipitation

  • ReasorJ

    New plasma products in development and recently introduced in the United States

    Plasmapheresis

    (1990)
  • PoolJG et al.

    High Potency AHF Concentrate Prepared from Cryoglobulin

    Precipitate

    (1964)
  • Heimburgervon N et al.

    Factor VIII—Konzentrat, hochgereinigt und in Lo¨sung erhitzt

    Arzneim Forsch

    (1981)
  • HeimburgerN et al.

    Factor VIII Concentrate, Hepatitis Safe: preparation and Properties

  • WinkelmanL et al.

    Severely heated therapeutic factor VIII concentrate of high specific activity

    Vox Sanguinis

    (1989)
  • HorowitzB et al.

    Inactivation of viruses in labile bhood derivatives. I. Disruption of lipidenveloped viruses by tri (n-butyl) phosphate detergent combination

    Transfusion

    (1985)
  • GazengelC

    Viral safety of solvent-detergent treated factor VIII concentrate

    Thrombosis and Haemostasis

    (1989)
  • GompertsED

    Procedure for the inactivation of viruses in clotting factor concentrates

    American Journal of Hematology

    (1986)
  • RubinsteinAJ et al.

    Inability of solvent-detergent (S-D) treated factor VIII concentrate to inactivate parvoviruses and non-lipid enveloped non-A, non-B hepatitis virus in factor VIII concentrate; advantages to using sterilizing 100°C dry heat treatment

    American Journal of Hematology

    (1990)
  • BurnoufT et al.

    A highly purified factor VIII:C concentrate prepared from cryoprecipitate by ion-exchange chromatography

    Vox Sanguinis

    (1991)
  • MyersR et al.

    Large scale preparation of a highly purified solvent-detergent treated factor VIII concentrate

    Vox Sanguinis

    (1991)
  • Heimburger N Personal...
  • WeinsteinRE

    Immunoaffinity purification of factor VIII

    Annals of Clinical and Laboratory Science

    (1989)
  • HaimovichJ et al.

    Human antimouse immunoglobulins in sera of patients treated chronically with monoclonal antibody-purified factor VIII

  • RodellNB et al.

    Safety of monoclonal antibody purified factor VIII

    Lancet

    (1990)
  • BuchananG et al.

    Reduced serum haptoglobin values in hemophiliacs receiving monoclonally purified factor VIII concentrates

    American Journal of Hematology

    (1990)
  • PasiKJ et al.

    In vitro and in vivo inhibition of monocyte phagocytic function by factor VIII concentrates: correlation with concentrate purity

    British Journal of Haematology

    (1990)
  • GompertsE et al.

    Immunologic function in hemophiliacs treated with plasma-derived MAb-purified factor VIII concentrate

    Transfusion

    (1990)
  • TooleJJ et al.

    Molecular cloning of a cDNA encoding human antihaemophilic factor

    Nature

    (1984)
  • TruettMA et al.

    Characterization of the polypeptide composition of human factor VIII:C and the nucleotide sequence and expression of the human kidney cDNA

    DNA

    (1984)

    • Cited by (15)

    • Improved delivery and antimetastatic effects of Stattic by self-assembled amphiphilic pendant-dendron copolymer micelles in breast cancer cell lines

      2020, Journal of Drug Delivery Science and Technology
      Citation Excerpt :

      It was found that P71D3/Stattic micelles did not cause hemolysis (<5%) or aggregation of red blood cells; hence, the samples are hemocompatible and suitable for systemic administration (Figs. S1 and S2 in the Supplementary Information). In addition to hemoglobin, approximately half the volume of blood is plasma, of which albumin is a major component [54]. Albumin serves significant physiological functions, particularly in the control of osmotic pressure via transportation of molecules into body circulation [55].

    • Bipolar value-driven joint product costing

      2001, Omega

    • Intensified capture of recombinant blood coagulation factors by continuous, integrated downstream processing

      2024, Journal of Chemical Technology and Biotechnology

    • Biochemical and cellular markers differentiate recovered, in-line filtered plasma, and plasma obtained by apheresis methods

      2022, Vox Sanguinis

    • Centrifuges

      2020, Between Making And Knowing: Tools In The History Of Materials Research

    • Studies of the Membrane-Protecting Potential of the Combination of 2-Ethyl-6-Methyl-Hydroxypyridine Succinate and Citicoline

      2019, Neuroscience and Behavioral Physiology
    View all citing articles on Scopus
    View full text
    Copyright © 1991 Published by Elsevier Ltd.